{
    "title": "GlaxoSmithKline boosted as US regulators say yes to whooping cough jab for unborn babies",
    "url": "https://www.dailymail.co.uk/money/markets/article-11300289/Glaxo-boosted-says-yes-whooping-cough-jab-unborn-babies.html",
    "date": "2022-10-10",
    "keywords": [
        "vaccine",
        "share",
        "fund",
        "chief",
        "walmsley",
        "drug",
        "use",
        "decision",
        "haleon",
        "money",
        "diy",
        "platform",
        "investment",
        "account",
        "fee",
        "glaxosmithkline",
        "executive",
        "emma",
        "boost",
        "cough",
        "babiesboostrix",
        "trimester",
        "disease",
        "boostrix",
        "relief",
        "glaxo",
        "exec",
        "dame",
        "pregnancy",
        "life",
        "immunisation",
        "april",
        "possibility",
        "zantac",
        "consumer",
        "healthcare",
        "spinoff",
        "time",
        "value",
        "market",
        "debut",
        "year",
        "takeover",
        "approach",
        "business",
        "brummer",
        "reality",
        "check",
        "truss",
        "britain",
        "govan",
        "yard",
        "steam",
        "decline",
        "light",
        "convenience",
        "store",
        "chain",
        "bank",
        "calm",
        "article",
        "capital",
        "risk",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "commission",
        "editorial",
        "independence",
        "investing"
    ],
    "category": [
        "money",
        "markets"
    ]
}